Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 1/2
This trial is looking at a drug called AZD5363 alongside paclitaxel for breast cancer that has spread into surrounding tissue or to another part of the body.
Doctors often use a chemotherapy drug called paclitaxel (Taxol) to treat breast cancer that has spread. But researchers are looking for ways to improve treatment. In this trial, they are looking at a drug called AZD5363.
Recruitment start: 1 October 2013
Recruitment end: 22 February 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Nicholas Turner
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 17 March 2016
CRUK internal database number: 10683